Hogan Lovells Publications
Doing business in the United States
15 January 2021
CounselBaltimore
Email scott.haiber@hoganlovells.com
Phone +1 410 659 2776
Fax +1 410 659 2701
Practice groupLitigation, Arbitration, and Employment
"Wickedly smart and calm in a storm."
Chambers USA
Scott Haiber has spent the past 20 years representing clients in their most complex litigation matters. Although he has broad experience in a wide variety of commercial litigation areas, he has focused his practice on corporate governance and products liability.
Scott represents corporations, REITs, directors, and officers in shareholder class and derivative litigation, including litigation involving M&A claims and federal securities claims. He also represents clients at the trial and appellate level in state and federal courts, and in commercial litigation. A member of both the Delaware and the Maryland Bar, Scott counsels management, and boards of directors on corporate governance and fiduciary duty issues.
Scott helps clients defend products liability claims, with a particular focus on the health care industry. His work in that industry is centered on cutting-edge and complex issues in litigation involving medical device manufacturers and pharmaceutical corporations.
Litigation: General Commercial (Maryland)
Chambers USA
Education
J.D., DePaul University College of Law, with honors, Order of the Coif, 1991
B.A., Bucknell University, Omicron Delta Epsilon Honor Society, 1988
Memberships
Member, Corporate Laws Committee, Business Law Section, Maryland State Bar Association
Member, Section on the Delaware General Corporation Law, Delaware State Bar Association
Past President, Maryland Lawyers' Chapter of the Federalist Society
Bar admissions and qualifications
Maryland
Delaware
Court admissions
U.S. District Court, District of Columbia
U.S. District Court, District of Delaware
U.S. District Court, District of Maryland
Represented the special litigation committee of a Maryland REIT in multi-jurisdictional litigation involving issues of corporate control.
Represented a laboratory services corporation in multiple jurisdictions in shareholder class and derivative M&A litigation matters.
Represented an Australian medical device manufacturer in numerous product liability actions in multiple jurisdictions across the U.S.
Represented a Maryland biotech company in a federal securities class action and related shareholder derivative action.
Represented a pharmaceutical corporation in multiple products liability actions involving tumor necrosis factor inhibitor biologic.
Represented directors of a Maryland REIT in recent M&A litigation.
Hogan Lovells Publications
15 January 2021
Hogan Lovells Publications
06 February 2018
Hogan Lovells Publications
13 July 2015